PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#compounding pharmacy ×

UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA scientists caution against easing peptide drug regulations for compounding pharmacies
FDA internal scientists advise against loosening controls on seven peptide ingredients intended for ulcerative colitis, insomnia and obesity, citing insufficient safety data.